达雷妥尤单抗与艾曲泊帕治疗急性淋巴细胞白血病ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍性贫血 - Suppr

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia.

作者信息

Pepeler Mehmet Sezgin, Dağdaş Simten, İşleyen Emel, Katayıfçı Gaye, Kılıçarslan Aydan, Özhamam Esra, Adakul Muhammed Talha, Öztürk Fahir, Ceran Funda, Özet Gülsüm

机构信息

University of Health Sciences Türkiye, Ankara Bilkent City Hospital, Clinic of Hematology, Ankara, Türkiye

Ankara Yıldırım Beyazıt University Faculty of Medicine, Department of Internal Medicine (Intern), Ankara, Türkiye

出版信息

Turk J Haematol. 2024 Dec 2;41(4):288-290. doi: 10.4274/tjh.galenos.2024.2024.0231. Epub 2024 Nov 18.

DOI:10.4274/tjh.galenos.2024.2024.0231

PMID:39552243

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11628761/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47c3/11628761/f8f9f9334b4a/TurkJHematol-41-288-figure-1.jpg

相似文献

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia.达雷妥尤单抗与艾曲泊帕治疗急性淋巴细胞白血病ABO血型不合异基因造血干细胞移植后纯红细胞再生障碍性贫血

Turk J Haematol. 2024 Dec 2;41(4):288-290. doi: 10.4274/tjh.galenos.2024.2024.0231. Epub 2024 Nov 18.

Daratumumab for pure red cell aplasia post ABO incompatible allogeneic hematopoietic stem cell transplant for aplastic anemia.达雷妥尤单抗治疗再生障碍性贫血患者 ABO 不合异基因造血干细胞移植后纯红细胞再生障碍。

Blood Cells Mol Dis. 2021 May;88:102464. doi: 10.1016/j.bcmd.2020.102464. Epub 2020 Jul 2.

Refractory Pure Red Blood Cell Aplasia Secondary to Major ABO-Incompatible Allogeneic Stem Cell Transplantation Successfully Treated With Daratumumab.达雷妥尤单抗成功治疗主要 ABO 血型不相合异基因干细胞移植继发的难治性纯红细胞再生障碍性贫血

J Hematol. 2023 Dec;12(6):277-282. doi: 10.14740/jh1195. Epub 2023 Dec 9.

Pure Red Cell Aplasia following ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation: Resolution with Daratumumab Treatment.ABO 血型不合异基因造血干细胞移植后纯红细胞再生障碍：达妥木单抗治疗后缓解。

Acta Haematol. 2021;144(6):683-687. doi: 10.1159/000515257. Epub 2021 Apr 22.

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.利妥昔单抗成功治疗ABO血型相合异基因造血干细胞移植术后患者的纯红细胞再生障碍性贫血

Case Rep Oncol. 2012 Jan;5(1):110-3. doi: 10.1159/000337022. Epub 2012 Feb 29.

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.通过移植前降低宿主抗供体同种凝集素预防主要或双向ABO血型不相合造血干细胞移植后的纯红细胞再生障碍。

Haematologica. 2009 Feb;94(2):239-48. doi: 10.3324/haematol.13356. Epub 2009 Jan 14.

Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease.病例报告：在 ABO 不合型干细胞移植治疗镰状细胞病后发生混合嵌合体的患者中，使用达雷妥尤单抗成功治疗纯红细胞再生障碍。

Front Immunol. 2023 Jun 23;14:1212007. doi: 10.3389/fimmu.2023.1212007. eCollection 2023.

Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation.依鲁替尼治疗主要 ABO 不相容造血干细胞移植后难治性纯红细胞再生障碍。

Biol Blood Marrow Transplant. 2018 Aug;24(8):1765-1770. doi: 10.1016/j.bbmt.2018.04.022. Epub 2018 Apr 21.

Successful treatment of pure red cell aplasia using therapeutic plasma exchange after ABO-incompatible hematopoietic stem cell transplant.采用治疗性血浆置换成功治疗 ABO 不相容造血干细胞移植后纯红细胞再生障碍。

J Clin Apher. 2023 Aug;38(4):495-499. doi: 10.1002/jca.22041. Epub 2023 Jan 26.

Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.主要 ABO 不相容造血干细胞移植后纯红细胞再生障碍的发生率。

Front Immunol. 2022 Feb 11;13:829670. doi: 10.3389/fimmu.2022.829670. eCollection 2022.

本文引用的文献

Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.ABO 血型不合与急性白血病异基因造血细胞移植结局的关系。

Am J Hematol. 2023 Apr;98(4):608-619. doi: 10.1002/ajh.26834. Epub 2023 Jan 16.

Post-hematopoietic stem cell transplantation immune-mediated anemia: a literature review and novel therapeutics.造血干细胞移植后免疫介导性贫血：文献回顾与新型治疗方法。

Blood Adv. 2022 Apr 26;6(8):2707-2721. doi: 10.1182/bloodadvances.2021006279.

Successful treatment of refractory pure red cell aplasia with eltrombopag after ABO-incompatible allogeneic hematopoietic stem cell transplantation.ABO 不相容异基因造血干细胞移植后使用艾曲波帕成功治疗难治性纯红细胞再生障碍。

J Zhejiang Univ Sci B. 2021 Aug 15;22(8):695-700. doi: 10.1631/jzus.B2000532.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1765-1770. doi: 10.1016/j.bbmt.2018.04.022. Epub 2018 Apr 21.

Marrow failure: a window into ribosome biology.骨髓衰竭：核糖体生物学的一扇窗口。

Blood. 2014 Oct 30;124(18):2784-92. doi: 10.1182/blood-2014-04-526301. Epub 2014 Sep 18.

The genetics of inherited sideroblastic anemias.遗传性铁粒幼细胞贫血的遗传学

Semin Hematol. 2002 Oct;39(4):270-81. doi: 10.1053/shem.2002.35637.

Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.ABO 血型不相合的亲属及非亲属骨髓移植后的移植物抗宿主病和供体定向血凝素滴度：移植物抗浆细胞效应的证据

Blood. 2000 Aug 1;96(3):1150-6.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Daratumumab and Eltrombopag for Pure Red Cell Aplasia Following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplant for Acute Lymphoblastic Leukemia.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献